Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 21 |
|
45469 |
Related information
Dosage
Adults and adolescents over 12 years: 1 film-coated tablet 3 times daily.
Children aged 6-12 years: 1 film-coated tablet twice daily.
Tablets are taken with some liquid (preferably a glass of water) in the morning, midday and evening. Tablets are not to be taken in a lying position.
After symptoms subside, it is recommended to continue the treatment for several days in order to prevent a relapse. The duration of treatment should not exceed 3 weeks.
Indications
Symptomatic treatment of acute bronchitis.
Traditional herbal medicinal product for use in the common cold.
Contra-Indications
Hypersensitivity to one of the components of the pharmaceutical.
Cases of severe hepatic diseases.
Special Precautions
The drug intended for short period of use, in cases of fever lasting for several days or in cases of shortness of breath or bloody sputum. The drug should be discontinued immediately if the condition does not improve in a week.
Cases of liver damage and hepatitis have been reported in connection with the use of medicinal products containing Pelargonium. The drug should be discontinued immediately if signs indicating liver function disorders occur.
The drug should not be used in children under the age of 6 years.
Patients with rare hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption should not take this drug.
See prescribing information for full details.
Side Effects
Gastro-intestinal complaints such as stomach pain, heartburn, nausea or diarrhea.
Increased liver values have been observed occasionally during treatment, reduced platelet levels have been observed during treatment.
See prescribing information for full details.
Drug interactions
None known to date.
Pregnancy and Lactation
Pregnancy: As yet there is no experience with the use of this medication, tablets in pregnant women. As a matter of precaution, the use of Kaloba® tablets during pregnancy should be avoided.
Lactation: It is not known whether ingredients of the Pelargonium sidoides root extract or their metabolites are excreted in breast milk. A risk for infants cannot be excluded. This drug should therefore not be taken during breastfeeding.
See prescribing information for full details.
Overdose
No cases of overdosage have been reported to date.
